Wells Fargo’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.5M Buy
+568,300
New +$9.89M ﹤0.01% 1860
2022
Q1
Sell
-100
Closed -$3K 7101
2021
Q4
$3K Buy
+100
New +$3.12K ﹤0.01% 6792
2019
Q3
Sell
-196,000
Closed -$148K 6384
2019
Q2
$148K Buy
+196,000
New +$5.78M ﹤0.01% 5128
2019
Q1
Sell
-48,400
Closed -$6K 6066
2018
Q4
$6K Buy
+48,400
New +$1.53M ﹤0.01% 6039

Other funds holding CC

Wells Fargo's CC Position: Q1 2026 in Review

Wells Fargo increased its Chemours (CC) stake by 121% in Q1 2026, buying an estimated $4.91M and bringing the position to 515,562 shares worth $11.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1931.

Wells Fargo first reported a position in CC in Q3 2015 and has held it in 43 quarters since. The position peaked at $24M in Q1 2021. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.

  • Wells Fargo held 515,562 shares of Chemours worth $11.4M as of Q1 2026.
  • Wells Fargo bought 281,948 Chemours shares in Q1 2026, an estimated $4.91M.
  • Chemours made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #1931 holding.
  • Wells Fargo first reported a position in Chemours in Q3 2015 and has held it in 43 quarters since.
  • Wells Fargo's Chemours position peaked at $24M in Q1 2021.
  • 448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.